Increased biological activity of 20-EPI-1,25-dihydroxyvitamin D3 is due to reduced catabolism and altered protein binding
- 1 March 1994
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 47 (6) , 987-993
- https://doi.org/10.1016/0006-2952(94)90409-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Vitamin D analogs with low affinity for the vitamin D binding protein: Enhanced in vitro and decreased in vivo activityJournal of Bone and Mineral Research, 1991
- 20-EPI-vitamin D3 analogues: A novel class of potent regulators of cell growth and immune responsesBiochemical Pharmacology, 1991
- Metabolism of a cyclopropane-ring-containing analog of 1α-hydroxyvitamin D3 in a hepatocyte cell modelBiochemical Pharmacology, 1990
- The Role of Vitamin D in Bone and Intestinal Cell DifferentiationAnnual Review of Nutrition, 1990
- Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton A trial of the development of vitamin D compounds which exhibit potent differentiation‐inducing activity without inducing hypercalcemiaFEBS Letters, 1987
- Side-chain hydroxylation of vitamin D3 and its physiological implicationsSteroids, 1987
- C(24)- and C(23)-oxidation, converging pathways of intestinal 1,25-dihydroxyvitamin D3 metabolism: identification of 24-keto-1,23,25-trihydroxyvitamin D3Biochemistry, 1983
- Biological activity assessment of the vitamin D metabolites 1,25-dihydroxy-24-oxo-vitamin D3 and 1,23,25-trihydroxy-24-oxo-vitamin D3Archives of Biochemistry and Biophysics, 1983
- Comparative study of the affinity of the serum vitamin d-binding proteinThe Journal of Steroid Biochemistry and Molecular Biology, 1980
- Receptors for 1,25(OH)2‐vitamin D3 enriched in cloned osteoblast‐like rat osteogenic sarcoma cellsFEBS Letters, 1980